Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors
Clinical trial NCT07357623 · RECRUITING
Trial details
- NCT number
- NCT07357623
- Sponsor
- Shanghai Chest Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-22
- Primary completion
- 2027-09-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.